Pharmaseal offers no-cost CTMS for COVID-19 trials

By Jenni Spinner contact

- Last updated on GMT

(Image: Getty/dragana991)
(Image: Getty/dragana991)

Related tags: COVID-19, Coronavirus, Clinical trials software

The company is making its Engility clinical trial management system available to trials on developing tests, treatments and vaccines for the virus.

Pharmaseal International is enabling academic institutions and pharmaceutical organizations to use Engility clinical trial management system (CTMS) for clinical research centered around COVID-19. According to the company, the cloud-based CTMS can be implemented rapidly for management of a clinical trial’s full cycle, including regulatory documentation.

Facilitating collaboration

Daljit Cheema, Pharmaseal CEO, told Outsourcing-Pharma that the CTMS has been engineered to enable collaboration, empowering users to work in the same system or integrate with other eClinical systems.

Our platform is designed to improve upon internal and external communication and enhance overall supply-chain management​,” he said. “It is designed to manage trials of all complexity, and therefore can substantially reduce the cost and time spent on duplicative or even unnecessary tasks that exist when not using a modern trial management solution​.”

What’s more, Cheema said, the company felt the need for such tools in the face of the global pandemic.

We believe that our intuitive and user-friendly system, which is rapidly implemented, can provide companies that are running COVID-19 trials a more secure, regulated system to plan, track and manage their trials increasing their efficiency and effectiveness to manage these clinical trials​,” he said. “It is our belief that our system can take some pressure off companies, allowing them to focus on bringing novel medicines to market​.”

Improving efficiency

Cheema added that facilitating collaboration makes a clinical trial organization more efficient, cost-effective and insightful.

This focus on interaction across multiple stakeholder groups not only provides greater insight into clinical trial data, but also reduces inefficiencies that have previously existed with siloed business functions​,” he said. “It is not just the system itself, but the standards that you build by using the system that will aid in streamlining processes and ultimately reducing cost pressures​.”

Cheema also explained the Engility CTMS enables users to readily centralize trial information, with a high degree of control and unified governance among collaborators. Additionally, it facilitates remote working, monitoring and sharing of information.

Engility is a software-as-a-service (SaaS) cloud platform engineered to deliver new product updates in a timely manner, within a continuous validation framework designed to accelerate innovation. According to the company, the platform is made to be flexible and scalable to meet an organization’s specific needs.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more